BioVie Inc. (BIVI)
NASDAQ: BIVI · Real-Time Price · USD
1.220
-0.030 (-2.40%)
At close: Jan 23, 2026, 4:00 PM EST
1.260
+0.040 (3.28%)
After-hours: Jan 23, 2026, 5:17 PM EST
BioVie Market Cap
BioVie has a market cap or net worth of $9.12 million as of January 23, 2026. Its market cap has decreased by -76.97% in one year.
Market Cap
9.12M
Enterprise Value
-15.15M
1-Year Change
-76.97%
Ranking
Category
Stock Price
$1.22
Market Cap Chart
Since September 18, 2020, BioVie's market cap has decreased from $52.00M to $9.12M, a decrease of -82.46%. That is a compound annual growth rate of -27.80%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 21, 2026 | 9.00M | 3.45% |
| Dec 31, 2025 | 8.70M | -75.49% |
| Dec 31, 2024 | 35.50M | -25.42% |
| Dec 29, 2023 | 47.60M | -79.93% |
| Dec 30, 2022 | 237.20M | 111.22% |
| Dec 31, 2021 | 112.30M | -53.40% |
| Dec 31, 2020 | 241.00M | 363.46% |
| Sep 18, 2020 | 52.00M | - |
View and export this data all the way back to 2020. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BioRestorative Therapies | 10.25M |
| Pulmatrix | 9.79M |
| Ernexa Therapeutics | 9.73M |
| SeaStar Medical Holding | 9.34M |
| PharmaCyte Biotech | 9.11M |
| MetaVia | 8.95M |
| Aptevo Therapeutics | 8.91M |
| XTL Biopharmaceuticals | 8.75M |